Elevating Post-Reproductive Care: Dr. Robyn Faye Joins Women’s HealthX 2026
Boston, MA — October 10: Women's HealthX is pleased to announce that Dr. Robyn Faye, Co-Director of the Jefferson Menopause Program and Gynecologist at Jefferson Health, will join the speaking faculty for this year's summit at Encore Boston Harbor.
As health systems strive to improve care for women navigating later reproductive and post-reproductive years, clinical leadership that bridges targeted gynecological expertise, complex menopausal management, and sexual wellness has never been more important. Dr. Faye brings more than 35 years of clinical experience in women's health, having transitioned from obstetrics to an exclusive focus on gynecology.
Throughout her career at Jefferson Health, she has championed approaches that seek to provide comprehensive, personalized care for women navigating menopause, pelvic pain, and vulvar disorders. Her work spans direct patient intervention and the advancement of specialized care models for diverse patient populations, including cancer survivors and the LGBTQ+ community.
She is widely recognized for integrating certified sexual counseling and gynecologic dermatology into routine practice to address often-overlooked clinical needs.
"My goal is to provide compassionate, personalized care that helps women thrive at every stage of life, guiding them toward an accurate diagnosis and effective treatment."
At Women's HealthX, Dr. Faye will help guide discussions across the summit, fostering collaboration between clinicians, advocates, and policymakers committed to advancing women's health.
Her participation reflects the collaborative spirit at the heart of Women's HealthX: bringing together leaders from across the healthcare landscape to move beyond conversation and toward measurable action.
We are delighted to welcome Dr. Robyn Faye to Women's HealthX and look forward to her leadership and perspective in Boston this December.
Women's HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.